New hybrid magnetic nanoparticles based on chitosan-maltose derivative for antitumor drug delivery.
Int J Biol Macromol
; 92: 561-572, 2016 Nov.
Article
en En
| MEDLINE
| ID: mdl-27451027
The aim of the present study is to obtain, for the first time, polymer magnetic nanoparticles based on the chitosan-maltose derivative and magnetite. By chemically modifying the chitosan, its solubility in aqueous media was improved, which in turn facilitates the nanoparticles' preparation. Resulting polymers exhibit enhanced hydrophilia, which is an important factor in increasing the retention time of nanoparticles in the blood flow. The preparation of nanoparticles relied on the double crosslinking technique (ionic and covalent) in reverse emulsion which ensures the mechanical stability of the polymer carrier. The characterization of both the chitosan derivative and nanoparticles was accomplished by Fourier Transform Infrared Spectroscopy, Nuclear Magnetic Resonance Spectroscopy, Scanning Electron Microscopy, Transmission Electron Microscopy, Atomic Force Microscopy, Vibrating Sample Magnetometry, and Thermogravimetric Analysis. The evaluation of morphological, dimensional, structural, and magnetical properties, as well as thermal stability and swelling behavior of nanoparticles was made from the point of view of the polymer/magnetite ratio. The study of 5-Fluorouracil loading and release kinetics as well as evaluating the cytotoxicity and hemocompatibility of nanoparticles justify their adequate behavior in their potential use as devices for targeted transport of antitumor drugs.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Sistemas de Liberación de Medicamentos
/
Quitosano
/
Nanopartículas de Magnetita
/
Maltosa
/
Antineoplásicos
Idioma:
En
Revista:
Int J Biol Macromol
Año:
2016
Tipo del documento:
Article